Bayshore Pharmaceuticals Recalls Metformin Hydrochloride Tablets Due to CGMP Deviations
Bayshore Pharmaceuticals is voluntarily recalling 594 bottles of Metformin Hydrochloride Extended-Release Tablets due to Current Good Manufacturing Practice (CGMP) deviations.
- Product
- METFORMIN HYDROCHLORIDE — METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide